UNSPSC 51171517: Almasilate

This classification denotes an aluminum silicates and antacid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OZQ8O62H53. European Medicines Agency schedules Almasilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05344MIG. Almasilate generally arises in the molecular formula 2AL.MG.8O.2SI.H2O.

The term ALMASILATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, no. 10 1980, list 20.) ALMASILATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule almasilate under HS 28421000 and SITC 52389. As of Q4 2014, ALMASILATE remains the US FDA Preferred Term for this commodity. SMILES: O.O[Si](=O)O.O[Si](=O)O.[Mg+2].[Al+3].[Al+3].

UNSPSC 51171517 Almasilate is a Commodity code that state and local governments use to procure drug-screening and diagnostic testing services, particularly specimen collection, immunoassay analysis, and confirmatory testing for offender monitoring and substance-abuse compliance programs. Recent solicitations show the code capturing laboratory services with SAMHSA or equivalent certification, staffed collection sites, and multi-panel urine screening with liquid chromatography or gas chromatography confirmation methodologies. The issuing bodies are primarily county-level community supervision and corrections departments managing offender testing programs, though the code also appears in state pharmacy and pharmaceutical procurement contexts where the connection to almasilate-specific testing is tangential. Collin County Community Supervision and Corrections Department (Texas) is a repeat and substantial buyer under this scope, soliciting offender specimen collection and drug testing services under RFP 2026-327, due July 23, 2026, with an estimated annual contract value of $600,000 and a two-year term with up to three optional one-year renewals.

Activity concentrates in Texas, with the Collin County RFP representing the most recent and clearly aligned opportunity. The Collin County procurement solicits staffing for two collection sites in Plano and McKinney (Monday–Friday 8:00 a.m. to 5:00 p.m., plus five Saturdays annually), an Interactive Voice Response system for randomized testing notifications, immunoassay screening with LC/MS/MS or GC/MS confirmation, electronic result reporting, and alternative methodologies including oral fluid and hair testing. The county expects approximately 25,031 annual tests across five-panel and six-panel screening models, with pricing submitted on a per-test basis and no additional surcharges permitted. Award, anticipated August 10, 2026, will be made to the responsible contractor offering the best value considering compliance, vendor qualifications, references, and cost. Two additional Texas opportunities (Texas HHS Commission's TPI Direct-to-Manufacturer Prescriptions RFI and Minnesota MMCAP's Generic Multi-Source Pharmaceuticals RFP) appear in the recent-opportunities block but do not involve almasilate testing or offender screening and represent code-tagging misalignment.